Cleared Traditional

K132165 - QLAB QUANTIFICATION SOFTWARE

K132165 is an FDA 510(k) clearance for QLAB QUANTIFICATION SOFTWARE, manufactured by Philips Ultrasound, Inc.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 28-day FDA review.

K132165 · Philips Ultrasound, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2013
Decision
28d
Days
Class 2
Risk

K132165 is an FDA 510(k) clearance for the QLAB QUANTIFICATION SOFTWARE. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Philips Ultrasound, Inc. (Andover, US). The FDA issued a Cleared decision on August 9, 2013 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Philips Ultrasound, Inc. devices

FDA 510(k) Submission Details - K132165

510(k) Number K132165 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 12, 2013
Decision Date August 09, 2013
Days to Decision 28 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
79d faster than avg
Panel avg: 107d · This submission: 28d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
MARK JOB

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1203
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K132165.
JUSHA-M32 MEDICAL DISPLAY
K131391 · Nanjing Jusha Display Technology Co., Ltd. · Aug 2013
SYNGO.MR GENERAL
K130749 · Siemens Medical Solutions USA, Inc. · Aug 2013
ORTHOVISION
K131570 · Ewoosoft Co., Ltd. · Aug 2013
ULTRAEXTEND USWS-900A V2.1 AND V3.1
K131822 · Toshiba America Medical Systems, In.C · Jul 2013
ESIE APPS SUITE
K132062 · Siemens Medical Solutions USA, Inc. · Jul 2013
21.3 INCH MONOCHROME DIGITAL MAMMOGRAPHY LCD MONITOR MS55I2 (ML21055, MD211G5)
K131137 · Jvckenwood Corporation · Jul 2013